Emergent BioSolutions
EBS
$3.16
Share price
-7.06%
Change (1 day)
-89.71%
Change (1 year)
Categories
Emergent BioSolutions (EBS) Fails to deliver data
Key failure to deliver metrics for Emergent BioSolutions :
- Last SEC data release: 2023-08-14
- Last 15 days FTD volume: $0.11 M
- Last 3 months FTD volume: $0.59 M
- Last year FTD volume: $4.95 M
Failures to deliver for Emergent BioSolutions (EBS) - 3 month history
Number of shares, 3 month chartBiweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013
Volume in USD (price x number of shares), data since 2013Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2023 | $3.32 M | 28.78% |
| 2022 | $2.58 M | -80.14% |
| 2021 | $13 M | -54.52% |
| 2020 | $28.59 M | 174.75% |
| 2019 | $10.4 M | -22.55% |
| 2018 | $13.43 M | 17.87% |
| 2017 | $11.39 M | 24.65% |
| 2016 | $9.14 M | 50.78% |
| 2015 | $6.06 M | 23.18% |
| 2014 | $4.92 M | 671.04% |
| 2013 | $0.63 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Pfizer PFE | $39.54 M | $0.40 B | 🇺🇸 USA |
 Merck MRK | $0.10 B | $0.46 B | 🇺🇸 USA |
 GlaxoSmithKline GSK | $3.3 M | $66.04 M | 🇬🇧 UK |
 Soligenix SNGX | $2.09 M | $2.19 M | 🇺🇸 USA |
 SIGA Technologies SIGA | $1.1 M | $32.98 M | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $0.88 M | $12.25 M | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $12.76 M | $38.36 M | 🇮🇱 Israel |